Computer modelling for glycoengineering of biosimilars

19:13 EDT 4 May 2017 | Generics and Biosimilars Initiative

In order to be approved by regulatory agencies, biosimilars are required to match all pharmacological properties of the originator protein drug to guarantee efficacy and alleviate safety concerns.

Original Article: Computer modelling for glycoengineering of biosimilars


More From BioPortfolio on "Computer modelling for glycoengineering of biosimilars"

Quick Search

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...